On September 8, 2020, the PolarityTE, Inc., issued a press release titled The Rental Agreement for LGC Genomics Oktopure Extraction Machine between Arches Market Data powered by QuoteMedia. From a small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to regenerate the target tissues. Entry into a Material Definitive Agreement. David Seaburg, Chief Executive Officer of PolarityTE commented, “We are excited by this opportunity to expand our testing capabilities and offer rapid and affordable COVID-19 testing for our community’s increasing demand. PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today announced that its subsidiary, Arches Research, Inc., has entered into a strategic partnership with Co-Diagnostics, Inc. (Nasdaq: CODX) to expand COVID-19 testing operations. POLARITYTE, the POLARITYTE logo, ARCHES, WHERE SELF REGENERATES SELF and WELCOME TO THE SHIFT are trademarks or registered trademarks of PolarityTE, Inc. View source version on businesswire.com: https://www.businesswire.com/news/home/20200908005238/en/, https://www.businesswire.com/news/home/20200908005238/en/. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. The firm seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Terms of Use. We would like to show you a description here but the site won’t allow us. 1960 S. 4250 West Subsequent events and developments may cause these forward-looking statements to change. Arches has previously been performing COVID-19 testing for its customers using Co-Diagnostics’ Logix Smart™ COVID-19 test kit. Find the latest PolarityTE, Inc. (PTE) stock quote, history, news and other vital information to help you with your stock trading and investing. PTE | Complete PolarityTE Inc. stock news by MarketWatch. PolarityTE, Inc. (Nasdaq: PTE) today announced that third quarter 2020 revenues will likely meet or exceed top end of the previous guided range of $2.7M to $3.2M. testing services and Co-Diagnostics manages all customer billing. Stay informed about our latest news and updates Sign Up Today >. PolarityTE is focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Company profile page for PolarityTE Inc including stock price, company news, press releases, executives, board members, and contact information If you have an ad-blocker enabled you may be blocked from proceeding. They are generally identified by words such as "believes," "may," "expects," "anticipates," "intend," "plan," "will," "would," "should" and similar expressions. David Seaburg, CEO, commented, “We continue to see strong execution and momentum in SkinTE sales. COVID-19 Testing Platform," a copy of which is attached to this report as an Real time PolarityTE Inc. (PTE) stock price quote, stock graph, news & analysis. On September 2, 2020, Arches Research, Inc., a subsidiary of PolarityTE, Inc. ("Arches") entered into two agreements with Co-Diagnostics, Inc. ("Co-Diagnostics").. View real-time stock prices and stock quotes for a full financial overview. Arches received a Clinical Laboratory Improvement Amendments of 1988 (CLIA) certificate of registration at the end of April and began testing for COVID-19 shortly thereafter. They are generally identified by words such as "believes," "may," "expects," "anticipates," "intend," "plan," "will," "would," "should" and similar expressions. PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today announced that its subsidiary, Arches Research, Inc., has entered into a strategic partnership with Co-Diagnostics, Inc. (Nasdaq: CODX) to expand COVID-19 testing operations. delivering specimens to Arches for COVID-19 testing for those customers of Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). Arches will perform specimen testing services for customers referred by PolarityTE, Inc. (the "Company") is presenting on September 14, 2020, at approximately 3:00 pm, Eastern Time, by live video webcast during the H.C. Wainwright 22nd Annual Global Investment Conference.The presentation slides used by the Company during the webcast are furnished herewith as Exhibit 99.1. minimum monthly purchase obligation for Co-Diagnostics tests and related Salt Lake City, UT 84104 POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES SELF and WELCOME TO THE SHIFT are trademarks or registered trademarks of PolarityTE, Inc. View source version on businesswire.com: https://www.businesswire.com/news/home/20200914005274/en/, https://www.businesswire.com/news/home/20200914005274/en/.